Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | 3 | IP-10 | 13.0 | 45 | ||||
RA1869 | 3 | IP-10 | 12.5 | 48 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | IP-10 | 12.0 | 59 | ||||
N2759 | 3 | IP-10 | 12.0 | 67 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | IP-10 | 11.0 | 55 | ||||
RA1931 | 3 | IP-10 | 13.0 | 63 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IP-10 | 15.0 | 64 | ||||
N2586 | 3 | IP-10 | 14.0 | 51 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 14.5 | 74 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 15.5 | 68 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 32.0 | 51 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 296.0 | 57 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 23.0 | 78 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 306.0 | 60 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 31.0 | 56 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 39.0 | 52 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 3334.5 | 72 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 5299.5 | 46 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 4594.0 | 55 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 9183.0 | 70 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 4108.0 | 48 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 7450.0 | 61 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 6412.5 | 50 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | IP-10 | 4402.0 | 62 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | IP-10 | 12.5 | 68 |